P/E at 64.81 vs Industry's 65.11: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Parity?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 64.81, marginally below the hospital industry average of 65.11. This near parity suggests the market values the company’s earnings similarly to its peers, reflecting neither a significant premium nor discount. Given the sector’s capital-intensive nature and growth prospects, such a valuation level is consistent with expectations for a large-cap hospital player. However, the narrow gap also raises questions about whether the stock’s recent performance justifies this valuation — previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside other metrics.

Performance Across Timeframes: A Tale of Contrasts

Examining returns over multiple periods reveals a stock that has outperformed the broader market consistently over the medium to long term. Over one year, Apollo Hospitals delivered a 17.93% gain, contrasting with the Sensex’s 6.03% decline. The year-to-date return is even more impressive at 25.07%, while the three-month return of 12.64% also beats the Sensex’s negative 0.98%. This sustained outperformance extends to longer horizons, with three-year returns at 68.98% versus 15.52% for the Sensex, and a remarkable 10-year return of 551.83% compared to the Sensex’s 173.15%. Yet, the short-term data shows some volatility: the stock has underperformed the sector by 0.31% today and lost 1.14% over the past week, though still outperforming the Sensex’s 1.49% decline. This divergence between short-term softness and longer-term strength — is this a temporary correction or a sign of shifting momentum? — invites closer scrutiny.

Moving Average Configuration: Technical Insights

The technical picture for Apollo Hospitals is intriguing. The stock currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling underlying strength and a positive medium to long-term trend. However, it remains below the 5-day moving average, indicating some recent short-term hesitation or profit-taking. This configuration suggests a stock that is in a recovery phase after a brief pullback, rather than a breakdown. The fact that the stock has gained after two consecutive days of decline supports this interpretation. The 2.18% proximity to its 52-week high of Rs 9008.9 further underscores resilience. The 5% surge partially reverses a 6.45% monthly decline — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Performance Context

The hospital sector has experienced mixed results recently, with a blend of positive, flat, and negative performances across constituent stocks. Apollo Hospitals stands out as a large-cap leader with consistent gains, outperforming many peers. Its market capitalisation of Rs 1,26,648.40 crore places it firmly among the sector’s giants, and its P/E ratio closely mirrors the industry average, reflecting investor confidence in its earnings stability. The sector’s overall performance has been challenged by regulatory pressures and rising costs, yet Apollo Hospitals has maintained relative strength. This resilience amid sector headwinds — does this signal sustainable competitive advantage or cyclical outperformance? — remains a key question for analysts.

Rating Reassessment and Historical Context

Previously rated Hold by MarketsMOJO, Apollo Hospitals Enterprise Ltd. had its rating reassessed on 11 May 2026. The updated evaluation reflects the company’s strong medium to long-term performance, valuation alignment with the sector, and technical indicators signalling recovery. The Mojo Score of 75.0 underscores a favourable assessment, though the current rating remains undisclosed. This reassessment comes after a period of consistent outperformance relative to the Sensex and sector peers, suggesting a positive shift in the company’s market standing. The question remains — should investors in Apollo Hospitals hold, buy more, or reconsider?

Collective Data Insights

Bringing together valuation, performance, and technical data, Apollo Hospitals Enterprise Ltd. presents a picture of a large-cap hospital stock trading at a valuation closely aligned with its sector peers. Its consistent outperformance over one, three, and five years, alongside a strong 10-year return, highlights its resilience and growth trajectory. The recent short-term volatility and slight underperformance relative to the sector in the past week suggest some caution, but the moving average configuration points to a recovery rather than a breakdown. The stock’s proximity to its 52-week high further supports this view. The reassessment of its rating from Hold to a new status reflects these dynamics — what does the current rating imply for investors?

Summary

In summary, Apollo Hospitals Enterprise Ltd. is a large-cap hospital stock with a valuation in line with its industry, strong medium to long-term returns, and a technical setup indicating recovery from recent short-term weakness. The rating reassessment reflects these factors, while sector performance remains mixed. Investors analysing this stock should weigh the consistent outperformance against recent short-term fluctuations and the technical signals that suggest a stabilising trend.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →